Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 24 studies | 57% ± 21% | |
classical monocyte | 22 studies | 42% ± 15% | |
monocyte | 14 studies | 36% ± 12% | |
neutrophil | 5 studies | 35% ± 10% | |
conventional dendritic cell | 4 studies | 26% ± 8% | |
intermediate monocyte | 4 studies | 63% ± 15% | |
plasmacytoid dendritic cell | 3 studies | 22% ± 4% | |
macrophage | 3 studies | 32% ± 18% | |
myeloid cell | 3 studies | 26% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 6 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1392.49 | 576 / 578 | 93% | 5.63 | 1072 / 1155 |
kidney | 51% | 85.71 | 45 / 89 | 84% | 4.40 | 761 / 901 |
intestine | 52% | 105.20 | 507 / 966 | 82% | 3.68 | 431 / 527 |
breast | 55% | 105.16 | 252 / 459 | 70% | 2.17 | 786 / 1118 |
stomach | 41% | 96.27 | 146 / 359 | 82% | 3.04 | 235 / 286 |
bladder | 43% | 135.00 | 9 / 21 | 72% | 4.65 | 362 / 504 |
uterus | 37% | 64.16 | 63 / 170 | 76% | 3.14 | 348 / 459 |
liver | 54% | 125.55 | 122 / 226 | 52% | 1.49 | 213 / 406 |
pancreas | 15% | 20.82 | 49 / 328 | 91% | 5.52 | 162 / 178 |
spleen | 100% | 4593.61 | 241 / 241 | 0% | 0 | 0 / 0 |
esophagus | 30% | 52.43 | 429 / 1445 | 64% | 1.75 | 117 / 183 |
prostate | 41% | 77.07 | 101 / 245 | 48% | 1.14 | 243 / 502 |
lymph node | 0% | 0 | 0 / 0 | 86% | 10.11 | 25 / 29 |
adrenal gland | 53% | 67.40 | 136 / 258 | 33% | 1.16 | 77 / 230 |
skin | 4% | 4.71 | 78 / 1809 | 81% | 4.62 | 382 / 472 |
adipose | 82% | 306.20 | 987 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 30846.34 | 755 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 2.74 | 35 / 45 |
thymus | 33% | 47.44 | 218 / 653 | 40% | 0.84 | 241 / 605 |
ovary | 19% | 23.06 | 35 / 180 | 50% | 1.12 | 217 / 430 |
heart | 49% | 87.77 | 420 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 46% | 109.01 | 618 / 1335 | 0% | 0 | 0 / 0 |
brain | 9% | 11.18 | 229 / 2642 | 26% | 0.99 | 180 / 705 |
eye | 0% | 0 | 0 / 0 | 30% | 0.61 | 24 / 80 |
muscle | 10% | 9.16 | 78 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0032695 | Biological process | negative regulation of interleukin-12 production |
GO_0032696 | Biological process | negative regulation of interleukin-13 production |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0050867 | Biological process | positive regulation of cell activation |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0002764 | Biological process | immune response-regulating signaling pathway |
GO_0061098 | Biological process | positive regulation of protein tyrosine kinase activity |
GO_0045087 | Biological process | innate immune response |
GO_0051928 | Biological process | positive regulation of calcium ion transport |
GO_0009986 | Cellular component | cell surface |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0032396 | Molecular function | inhibitory MHC class I receptor activity |
Gene name | LILRA5 |
Protein name | Leukocyte immunoglobulin-like receptor subfamily A member 5 (CD85 antigen-like family member F) (Immunoglobulin-like transcript 11) (ILT-11) (Leukocyte immunoglobulin-like receptor 9) (LIR-9) (CD antigen CD85f) Immunoglobulin-like receptor subfamily A member 5 |
Synonyms | LILRB7 LIR9 ILT11 |
Description | FUNCTION: May play a role in triggering innate immune responses. Does not seem to play a role for any class I MHC antigen recognition. . |
Accessions | ENST00000618711.4 [A6NI73-1] ENST00000621482.2 [A6NI73-3] ENST00000486742.2 [A6NI73-2] ENST00000619516.3 [A6NI73-4] A0A0U4ARJ3 ENST00000615820.1 [A6NI73-2] ENST00000621042.4 [A6NI73-1] ENST00000612621.4 [A6NI73-1] ENST00000620091.4 [A6NI73-1] ENST00000620692.4 [A6NI73-3] ENST00000612266.4 [A6NI73-4] ENST00000432233.8 [A6NI73-1] ENST00000620898.4 [A6NI73-2] A6NI73 ENST00000611164.4 [A6NI73-2] ENST00000614299.4 [A6NI73-2] ENST00000613559.1 [A6NI73-3] ENST00000616133.1 [A6NI73-4] |